We've raised $25M from leading philanthropists
Accelerating a cure for Long Covid
with Silicon Valley speed.
100M patients, no approved treatments. Let's change that.
The evidence to cure Long Covid exists, but it's not in the healthcare system. It's scattered across patient communities, EHRs, and research cohorts. Patients are already recovering from off-label treatments, but none of this data has crossed the chasm into actual drug development.
We've acquired the largest patient dataset.
Our models rank which treatments actually work.
Patients are recovering on off-label drugs, but no one is measuring these outcomes systematically. We run our models against the full dataset to rank therapeutics by what's working, and for whom.
We fund clinical trials to get those treatments formally approved.
Off-label drugs are helping patients right now. But without approved indications, most doctors won't prescribe it and insurance won't cover it. We fund trials to re-indicate the highest-signal candidates.
We're funding the first diagnostic biomarker.
There is no blood test for Long Covid. That makes trials harder to run, treatments harder to evaluate, and patients harder to believe. We're deploying capital to research institutions to develop validated biomarkers.
The science exists. The patients exist. The funding doesn't.
We raised $25M because the bottleneck was never knowledge, but capital and infrastructure. Our team spans ML, computational biology, and clinical research. We're based in San Francisco and we're moving fast.